MPM BioVentures IV QP LP's Net Worth
$0
Who is MPM BioVentures IV QP LP?
MPM BioVentures IV QP LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Pacira Pharmaceuticals, Inc., Syndax Pharmaceuticals Inc, Epizyme, Inc., CHIASMA, INC, PEPLIN INC, TriVascular Technologies, Inc., Conatus Pharmaceuticals Inc, and MEMORY PHARMACEUTICALS CORP.
SEC CIK
MPM BioVentures IV QP LP's CIK is 0001358309
Past Insider Trading and Trends
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
TriVascular Technologies, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.78M |
—
|
—
| 1.78M |
Apr 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Syndax Pharmaceuticals Inc (SNDX) Snapshot price: $19.1
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 2.17M |
—
|
—
| 2.17M |
Mar 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
CHIASMA, INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 5.68M |
—
|
—
| 5.68M |
Jul 21
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Epizyme, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -16.20% | -466.67K |
$29.25 | -$13,649,980.50 | 2.41M |
Feb 10
| |||
Form 4
| +1,515.25% | 2.7M |
—
|
—
| 2.88M |
Jun 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Pacira Pharmaceuticals, Inc. (PCRX) Snapshot price: $13.89
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -15.20% | -500.00K |
$27.86 | -$13,930,000.00 | 2.79M |
Mar 11
| |||
Form 4
| +16.31% | 461.54K |
$6.50 | $2,999,997.00 | 3.29M |
Nov 21
| |||
Form 4/A
| +2,942.53% | 2.74M |
$7.00 |
—
| 2.83M |
Feb 8
| |||
Form 4
| +2,942.53% | 2.74M |
$7.00 |
—
| 2.83M |
Feb 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||